Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 1,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · derivative · entry 17 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,028 Underlying: Common Stock · 1,028 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F10 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 448 | $243.45 | $109,065.60 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 8 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,769 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 1,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 7 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 15 | $243.45 | $3,651.75 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 6 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,191 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 1,028 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000036 · wk-form4_1771467100.xml · nonDerivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
GrantRestricted Share Units · Derivative | 3,940 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · derivative · entry 14 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,940 Underlying: Common Stock · 3,940 shares Expires not disclosed F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 54,869 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · derivative · entry 13 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,869 Underlying: Common Stock · 54,869 shares Expires 2036-02-15 F8 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionRestricted Share Units · Derivative | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · derivative · entry 12 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,692 Underlying: Common Stock · 1,847 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionRestricted Share Units · Derivative | 1,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · derivative · entry 11 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,594 Underlying: Common Stock · 1,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 945 | $243.45 | $230,060.25 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · nonDerivative · entry 8 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,451.001 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · nonDerivative · entry 7 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,396.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 816 | $243.45 | $198,655.20 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · nonDerivative · entry 6 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,549.001 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 1,594 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000037 · wk-form4_1771467106.xml · nonDerivative · entry 5 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,365.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
GrantRestricted Share Units · Derivative | 1,944 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · derivative · entry 14 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,944 Underlying: Common Stock · 1,944 shares Expires not disclosed F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 27,076 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · derivative · entry 13 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,076 Underlying: Common Stock · 27,076 shares Expires 2036-02-15 F8 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
Exercise / conversionRestricted Share Units · Derivative | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · derivative · entry 12 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,126 Underlying: Common Stock · 1,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
Exercise / conversionRestricted Share Units · Derivative | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · derivative · entry 11 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 961 Underlying: Common Stock · 961 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 544 | $243.45 | $132,436.80 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · nonDerivative · entry 8 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,568 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · nonDerivative · entry 7 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
Tax withholdingCommon Stock | 492 | $243.45 | $119,777.40 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · nonDerivative · entry 6 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,049 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:11 UTC |
Forminard ElizabethEVP, Chief Legal Officer
|
Exercise / conversionCommon Stock | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000038 · wk-form4_1771467112.xml · nonDerivative · entry 5 Forminard Elizabeth · CIK 0001950802 · EVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
GrantRestricted Share Units · Derivative | 3,546 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 13 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,546 Underlying: Common Stock · 3,546 shares Expires not disclosed F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F4 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 49,382 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 12 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,382 Underlying: Common Stock · 49,382 shares Expires 2036-02-15 F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionRestricted Share Units · Derivative | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 11 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,692 Underlying: Common Stock · 1,847 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F3 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F4 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionRestricted Share Units · Derivative | 1,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · derivative · entry 10 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,349 Underlying: Common Stock · 1,349 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F4 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Tax withholdingCommon Stock | 528 | $243.45 | $128,541.60 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 4 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,941 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionCommon Stock | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 3 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Tax withholdingCommon Stock | 385 | $243.45 | $93,728.25 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 2 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,622 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
Exercise / conversionCommon Stock | 1,349 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000039 · wk-form4_1771467119.xml · nonDerivative · entry 1 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
GrantRestricted Share Units · Derivative | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · derivative · entry 16 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700 Underlying: Common Stock · 700 shares Expires not disclosed F11 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F11 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F11 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 4,871 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · derivative · entry 15 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,871 Underlying: Common Stock · 4,871 shares Expires 2036-02-15 F10 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionRestricted Share Units · Derivative | 344 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · derivative · entry 14 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 687 Underlying: Common Stock · 344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionRestricted Share Units · Derivative | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · derivative · entry 13 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338 Underlying: Common Stock · 339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F9 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
Tax withholdingCommon Stock | 95 | $243.45 | $23,127.75 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · nonDerivative · entry 8 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,682 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 344 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · nonDerivative · entry 7 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
Tax withholdingCommon Stock | 94 | $243.45 | $22,884.30 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · nonDerivative · entry 6 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,433 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000040 · wk-form4_1771467125.xml · nonDerivative · entry 5 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 3,863 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 23 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,863 Underlying: Common Stock · 3,863 shares Expires not disclosed F15 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F15 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F15 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F13 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 53,793 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 22 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,793 Underlying: Common Stock · 53,793 shares Expires 2036-02-15 F14 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 21 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,754 Underlying: Common Stock · 1,878 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F13 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · derivative · entry 20 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,971 Underlying: Common Stock · 1,971 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F13 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 817 | $243.45 | $198,898.65 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 8 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,961 F4 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 1,878 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 7 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 858 | $243.45 | $208,880.10 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,900 F4 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000041 · wk-form4_1771467131.xml · nonDerivative · entry 5 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Mulholland KristenEVP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 1,459 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000042 · wk-form4_1771467137.xml · derivative · entry 14 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,459 Underlying: Common Stock · 1,459 shares Expires not disclosed F9 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F9 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Mulholland KristenEVP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 20,322 | $0.00 Strike: $243.45 | $0.00 |
DisclosureSEC source: 0000200406-26-000042 · wk-form4_1771467137.xml · derivative · entry 13 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,322 Underlying: Common Stock · 20,322 shares Expires 2036-02-15 F8 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 575 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000042 · wk-form4_1771467137.xml · derivative · entry 12 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,150 Underlying: Common Stock · 575 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F6 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 419 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-26-000042 · wk-form4_1771467137.xml · derivative · entry 11 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418 Underlying: Common Stock · 419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. F7 · balance_after: Each RSU represents a contingent right to receive one share of Company Common Stock. Read SEC document |
| February 15, 2026 Filed Feb 19, 2026 02:12 UTC |
Mulholland KristenEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 251 | $243.45 | $61,105.95 |
DisclosureSEC source: 0000200406-26-000042 · wk-form4_1771467137.xml · nonDerivative · entry 8 Mulholland Kristen · CIK 0002037288 · EVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,830 F2 · shares: Shares withheld for payment of taxes upon vesting of RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.